Navigation Links
EASL publishes first comprehensive literature review on the burden of liver disease in Europe
Date:2/21/2013

Brussels and Geneva, 20th February 2013 --- Major progress has been made in the past 30 years in the knowledge and management of liver disease, yet approximately 29 million Europeans still suffer from a chronic liver condition.

The European Association for the Study of the Liver (EASL) today unveiled its new publication The burden of liver disease in Europe: a review of available epidemiological data. Key findings in the report suggest that alcohol consumption, viral hepatitis B and C and metabolic syndromes related to overweight and obesity are the leading causes of cirrhosis and primary liver cancer in Europe. The report is the result of a review of 260 epidemiological studies published in the last five years in order to survey the current state of evidence on the burden of liver disease in Europe and its causes. Speaking immediately before a launch event, hosted by Mr Stephen Hughes MEP, at the European Parliament, Prof. Mark Thursz, EASL Secretary-General, noted that "although the incidence and prevalence of liver disease in Europe is alarming, what is encouraging to see is that each of the major causes of liver disease is potentially amenable to prevention and treatment. This means we all have an opportunity to make a difference, through implementing the right policy changes. The report shows us the importance of tackling the excessive consumption of alcohol which is the leading cause of cirrhosis and primary liver cancer. The Scottish Minimum Unit Pricing of alcohol is an example of the urgent measures needed and we continue to draw attention to the importance of its implementation".

Stephen Hughes, MEP, host of the launch event at the European Parliament in Brussels, welcomed the publication of the report and took the opportunity to announce that he and a group of like-minded MEPs with an interest in Liver Disease had recently decided to create the "Friends of the Liver MEP Group". Mr Hughes, who is chair of the group, said "we hope that by creating this informal group this will enable us to raise awareness within the European Parliament of the seriousness of the liver disease epidemic and will encourage every single one of those 29 million Europeans who suffer from a chronic liver condition. They have not been forgotten. They will not be forgotten".

Prof. Markus Peck, EASL Vice-Secretary and Prof. Patrizia Burra, EASL EU Policy Councillor, both of whom were speakers at the launch event, welcomed the report's publication and Mr Hughes' announcement and said that "EASL looks forward to working with Members of the European Parliament as we take the report findings and use them to draw attention to the importance of tackling the major risk factors for liver disease and also to ensure that enough is done in order that cost-effective prevention programmes can be implemented and novel treatments to tackle liver disease and avoidable deaths in Europe are developed".


'/>"/>

Contact: Margaret Walker
margaret.walker@easloffice.eu
41-799-461-549
European Association for the Study of the Liver
Source:Eurekalert

Related medicine news :

1. SomaLogic publishes proteomic biomarker analysis of lung cancer tissue samples
2. Moffitt researcher publishes book on nutritional management of cancer treatment effects
3. Ear, Nose & Throat Journal publishes research on breakthrough treatment for tonsil stones
4. Natural Sciences Repository Publishes Chromatography and Acidic Compounds Resources
5. ASTRO publishes Safety is No Accident: A Framework for Quality Radiation Oncology and Care
6. Annals of Internal Medicine publishes new CDC recommendations on hepatitis C screening
7. Maturitas publishes clinical guide on low-dose vaginal estrogens for vaginal atrophy
8. Using an HRA to Comply with San Francisco's HCSO Requirements - Zane Benefits Publishes Information
9. Zane Benefits Publishes Information About Over-the-Counter (OTC) Medicines, Drugs and HRAs
10. Defined Contribution: A Healthcare Win for Brokers, Employers & Employees - Zane Benefits Publishes Information
11. ISA Surgical Publishes Real Stories of the Benefits of Medical Tourism In Mexico From US And Canadian Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... ... April 25, 2017 , ... As Spring reignites ... defects research related to Zika virus during pregnancy, as well as other prenatal ... important science. , The Teratology Society is an international and ...
(Date:4/25/2017)... ... April 25, 2017 , ... Saad B. Chaudhary, MD is committed to providing the ... or chronic problems, I focus on preventative care with all my patients to alleviate possible ... questions, always feel free to contact my office and my trained staff will assist you ...
(Date:4/25/2017)... ... 25, 2017 , ... There is no better place in South Florida to ... in the May issue of Consumer Reports focused on heart health. , The ... during and after coronary bypass and aortic valve replacement procedures. , Consumer Reports ...
(Date:4/24/2017)... ... April 24, 2017 , ... Emmanuel College is introducing ... advance their careers. Beginning in the fall of 2017, Emmanuel’s program will allow registered ... few as 16 months and for as little as $14,528. These changes will enable ...
(Date:4/24/2017)... ... ... The Santana Telehealth Project was honored with the 2017 ATA Humanitarian Award. The ... conference, on April 23 in Orlando, FL. , “I am proud that ATA is ... poor and underserved in other parts of the world,” said Jonathan Linkous, CEO of ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... 20, 2017  AbbVie (NYSE: ABBV), a global ... of chronic hepatitis C virus (HCV) infected patients ... and compensated cirrhosis (Child-Pugh A) achieved sustained virologic ... with its investigational, pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). ... following 12 weeks of G/P treatment without ribavirin. ...
(Date:4/19/2017)... - CRH Medical Corporation (TSX: CRH) (NYSE MKT: CRHM) (the "Company"), announces that ... Conference 2017 at the Sheraton Hotel in Toronto, Ontario ... of the Company is scheduled to present on Tuesday, May 2 ... the Chairman of the Board, Tony Holler will also ... For more ...
(Date:4/19/2017)... , April 19, 2017 Global Prostate ... report on the prostate cancer therapeutics market analyzes ... market. Increasing prevalence of prostate cancer, launch of ... the development of new drugs & therapeutic biological ... drug due to lesser side effects are some ...
Breaking Medicine Technology: